• LAST PRICE
    26.0400
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    11.1900/ 1
  • Ask / Lots
    30.0000/ 12
  • Open / Previous Close
    0.0000 / 26.0400
  • Day Range
    ---
  • 52 Week Range
    Low 9.4700
    High 27.0792
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 25.27
TimeVolumeVRDN
09:32 ET533425.5
09:33 ET349525.76
09:35 ET230526.1649
09:37 ET997926.01
09:39 ET251725.9
09:42 ET271925.67
09:44 ET10025.81
09:48 ET60025.55
09:50 ET100825.66
09:53 ET10025.7
09:55 ET180825.905
09:57 ET240026.005
10:00 ET40026.005
10:02 ET381625.89
10:04 ET20025.92
10:06 ET90025.86
10:08 ET30025.84
10:09 ET120025.84
10:11 ET768126.06
10:13 ET75626
10:15 ET559726.02
10:18 ET70026.02
10:20 ET319125.88
10:22 ET20025.835
10:24 ET10025.825
10:26 ET60025.825
10:27 ET10025.825
10:29 ET131025.8
10:33 ET189625.885
10:36 ET590926
10:38 ET100026.03
10:40 ET1897726
10:42 ET40026.015
10:44 ET474026.035
10:45 ET415626.01
10:47 ET373826
10:49 ET192025.94
10:51 ET58326
10:54 ET70026
10:56 ET87625.98
10:58 ET270026
11:00 ET20026
11:02 ET40026
11:03 ET70025.98
11:05 ET410125.94
11:07 ET90025.94
11:09 ET33025.935
11:12 ET10025.88
11:14 ET112225.9
11:16 ET61225.955
11:18 ET30025.94
11:20 ET370025.96
11:21 ET230026
11:23 ET892626.01
11:25 ET1827325.995
11:27 ET121725.97
11:30 ET100025.98
11:32 ET200026
11:34 ET50026
11:36 ET1552026
11:38 ET60026
11:39 ET185026.005
11:41 ET110325.99
11:43 ET491026
11:48 ET5640726
11:50 ET60025.995
11:52 ET100026
11:54 ET20025.99
11:57 ET10766126.1
11:59 ET442826
12:01 ET203325.985
12:03 ET3252525.9573
12:06 ET136025.875
12:08 ET20025.82
12:12 ET30025.675
12:14 ET20025.59
12:15 ET359325.41
12:19 ET30025.395
12:21 ET80625.42
12:24 ET164125.535
12:28 ET173925.3365
12:30 ET88225.28
12:32 ET30025.25
12:33 ET50025.2
12:35 ET150125.14
12:37 ET380025
12:39 ET120024.985
12:42 ET30025.015
12:44 ET10025.02
12:46 ET344125.03
12:48 ET10025
12:50 ET10025.015
12:51 ET20025.01
12:53 ET10025.01
12:55 ET30025
12:57 ET20025.005
01:00 ET20025.045
01:02 ET240025.165
01:04 ET151125.095
01:06 ET72125.17
01:08 ET60425.23
01:09 ET100025.17
01:11 ET30025.08
01:13 ET20025.07
01:15 ET167125.07
01:18 ET20025.07
01:20 ET12325.01
01:22 ET70525
01:24 ET1860025.15
01:26 ET60025.19
01:27 ET78125.24
01:29 ET16025.2076
01:31 ET10025.14
01:33 ET20025.205
01:36 ET10025.205
01:38 ET110025.35
01:40 ET50025.38
01:42 ET16025.36
01:44 ET421925.6
01:45 ET60025.675
01:47 ET120025.755
01:49 ET10025.78
01:51 ET122225.72
01:54 ET239425.715
01:56 ET150825.69
01:58 ET92725.81
02:00 ET125725.84
02:02 ET261125.865
02:03 ET56025.85
02:05 ET100025.85
02:07 ET10025.88
02:09 ET40025.94
02:12 ET20026
02:14 ET20026.01
02:16 ET977926.01
02:18 ET71626.005
02:20 ET242225.8061
02:21 ET435226
02:23 ET10026
02:25 ET561326.05
02:27 ET125825.94
02:30 ET20025.95
02:32 ET40625.99
02:34 ET50025.9
02:36 ET50025.95
02:38 ET130025.91
02:39 ET30025.925
02:41 ET10025.92
02:43 ET60025.86
02:45 ET177425.8
02:48 ET30025.8
02:50 ET20025.855
02:52 ET132325.82
02:54 ET10025.785
02:56 ET80025.772
02:57 ET30025.76
02:59 ET40025.79
03:01 ET90025.76
03:03 ET20025.77
03:06 ET30025.78
03:08 ET111325.775
03:10 ET455525.99
03:12 ET102225.955
03:15 ET264925.98
03:17 ET92525.9799
03:19 ET1547225.99
03:21 ET573225.97
03:24 ET10025.97
03:26 ET3863626.32
03:28 ET81526.28
03:30 ET30026.19
03:32 ET2881726.09
03:33 ET90026.105
03:35 ET100026.01
03:37 ET250826.03
03:39 ET30026.03
03:42 ET360026.06
03:44 ET233326.08
03:46 ET152826.11
03:48 ET92026.24
03:50 ET356426.1675
03:51 ET1022826.2799
03:53 ET327626.16
03:55 ET705126.11
03:57 ET579926.111
04:00 ET1965326.04
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVRDN
Viridian Therapeutics Inc
1.0B
-6.2x
---
United StatesARQT
Arcutis Biotherapeutics Inc
1.0B
-2.9x
---
United StatesACRS
Aclaris Therapeutics Inc
1.1B
-12.3x
---
United StatesKURA
Kura Oncology Inc
1.1B
-7.7x
---
United StatesIOVA
Iovance Biotherapeutics Inc
1.0B
-2.6x
---
United StatesREPL
Replimune Group Inc
993.8M
-7.3x
---
As of 2022-12-02

Company Information

Viridian Therapeutics, Inc. is a biotechnology company that is focused on advancing treatments for patients suffering from serious diseases. The Company is engaged in developing two product candidates, VRDN-001 and VRDN-002, to treat patients who suffer from thyroid eye disease (TED). TED is a debilitating autoimmune disease that causes inflammation and fibrosis within the orbit of the eye, which can cause double vision, pain, and potential blindness. Its lead product candidate, VRDN-001, is a differentiated humanized monoclonal antibody targeting insulin-like growth factor-1 receptor (IGF-1R), a clinically and commercially validated target for the TED. It has initiated a Phase I/II clinical trial of VRDN-001. Its second product candidate, VRDN-002, is a distinct IGF-1R antibody that incorporates half-life extension technology, and is designed to support administration as a convenient, low volume, subcutaneous injection to treat patients who suffer from TED.

Contact Information

Headquarters
203 CRESCENT STREET BLDG. 17, SUITE 102BWALTHAM, MA, United States 02453
Phone
617-272-4600
Fax
302-655-5049

Executives

Independent Chairman of the Board
Tomas Kiselak
President, Chief Executive Officer, Director
Jonathan Violin
Chief Financial Officer, Chief Business Officer
Kristian Humer
Chief Operating Officer
Carrie Melvin
Senior Vice President, General Counsel
Lara Meisner

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.0B
Revenue (TTM)
$1.9M
Shares Outstanding
40.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.93
EPS
$-4.21
Book Value
$7.85
P/E Ratio
-6.2x
Price/Sales (TTM)
557.2
Price/Cash Flow (TTM)
---
Operating Margin
-6,077.57%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.